We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIF icon
4426
SIFCO Industries
SIF
$122M
$4.78K ﹤0.01%
1,028
-269
-21% -$1.06K
ELTX icon
4427
Elicio Therapeutics
ELTX
$82.7M
$4.78K ﹤0.01%
+950
New +$4.21K
NEPH icon
4428
Nephros
NEPH
$48.9M
$4.77K ﹤0.01%
2,791
-882
-24% -$1.74K
CARV
4429
DELISTED
Carver Bancorp
CARV
$4.77K ﹤0.01%
2,482
-3,160
-56% -$5.82K
FTEK icon
4430
Fuel Tech
FTEK
$45.3M
$4.76K ﹤0.01%
4,538
-222
-5% -$227
MAGN
4431
Magnera Corp
MAGN
$435M
$4.76K ﹤0.01%
204
-799
-80% -$16.7K
FWDI
4432
Forward Industries Inc
FWDI
$305M
$4.76K ﹤0.01%
1,275
+18
+1% +$70
ARMP icon
4433
Armata Pharmaceuticals
ARMP
$177M
$4.75K ﹤0.01%
2,005
-3,059
-60% -$7.82K
DRMA icon
4434
Dermata Therapeutics
DRMA
$6.23M
$4.74K ﹤0.01%
289
+116
+67% +$2.31K
LUMO
4435
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.74K ﹤0.01%
1,225
-2,357
-66% -$6.53K
QID icon
4436
ProShares UltraShort QQQ
QID
$242M
$4.74K ﹤0.01%
131
-84
-39% -$3.29K
CLOA icon
4437
BlackRock ETF Trust II iShares AAA CLO Active ETF
CLOA
$2.26B
$4.73K ﹤0.01%
+91
New +$4.72K
CELU icon
4438
Celularity
CELU
$20.3M
$4.73K ﹤0.01%
1,592
-383
-19% -$1.13K
TTOO
4439
DELISTED
T2 Biosystems, Inc
TTOO
$4.73K ﹤0.01%
2,399
-5,268
-69% -$20K
MSOS icon
4440
AdvisorShares Pure US Cannabis ETF
MSOS
$936M
$4.72K ﹤0.01%
659
+411
+166% +$2.92K
NXXT
4441
NextNRG Inc
NXXT
$53.8M
$4.72K ﹤0.01%
1,570
-304
-16% -$1.14K
ICAD
4442
DELISTED
iCAD Inc
ICAD
$4.72K ﹤0.01%
3,016
-818
-21% -$1.17K
HYPR icon
4443
Hyperfine
HYPR
$95M
$4.71K ﹤0.01%
4,366
-13,076
-75% -$13.9K
DALN
4444
DELISTED
DallasNews
DALN
$4.71K ﹤0.01%
1,125
-1,537
-58% -$6.17K
BOTJ icon
4445
Bank Of The James
BOTJ
$126M
$4.71K ﹤0.01%
343
-378
-52% -$4.94K
UUU icon
4446
Universal Safety Products Inc
UUU
$10.3M
$4.71K ﹤0.01%
4,061
-85
-2% -$113
RDI icon
4447
Reading International Class A
RDI
$33.8M
$4.69K ﹤0.01%
2,880
-4,418
-61% -$6.89K
AMPG icon
4448
AmpliTech
AMPG
$153M
$4.69K ﹤0.01%
6,013
+355
+6% +$340
DBD icon
4449
Diebold Nixdorf
DBD
$2.44B
$4.69K ﹤0.01%
+105
New +$4.34K
HNNA icon
4450
Hennessy Advisors
HNNA
$79M
$4.69K ﹤0.01%
471
-22
-4% -$198

Similar funds

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.